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The presence of food-borne disease in food systems creates direct and indirect economic impacts. These 
include the losses caused by the negative effects of disease itself when people are ill or die leading to 
reduced productivity, loss of income, and human suffering. In animal populations, similar losses occur when 
animals are ill or die leading to production losses and/or animal welfare issues. To avoid such losses, efforts 
to prevent, control or eradicate disease can be undertaken but in return also generate economic costs. 
Economic analyses in this context investigate how resources are allocated to activities and how to balance 
direct losses against expenditure to reduce the impact of disease.
When considering economic aspects of surveillance, the instant thought is often: “How much does it cost?” 
In order to estimate the costs of surveillance, all activities related to a programme need to be identified and the 
associated costs estimated. This should include costs for tests, farm visits and consumables, but also investments 
in infrastructure such as databases as well as labour costs. Although this may appear to be a relatively straight-
forward exercise, such costs may be difficult to collect in retrospect. For example, if surveillance tasks are only part 
of a person’s job, it may be difficult to allocate exact time and therefore labour costs. Also, some activities may 
be subsidised and costs may therefore not reflect true market value. This is sometimes the case for laboratory 
diagnostics where tests conducted as part of a large programme are not comparable with market costs. Such 
differences also impede comparisons between industries and countries with different pricing policies. 
However, collection of costs is only the first step. A more interesting question could be: “Is it cost-
effective?” This means, are the resources invested such that they provide the effective results. Cost-
effectiveness is normally expressed using ratios of cost per effectiveness outcome, i.e. cost in relation to 
the results of a programme in natural non-monetary units. Therefore, cost-effectiveness can be measured 
in a range of units, including the “information-cost ratio”. The latter describes how much information 
can be obtained per invested amount. Cost-effectiveness largely depends on the design of a surveillance 
programme. There are simple or more complex designs as surveillance systems may consist of one or 
several components, each with their related performance. The performance of a surveillance activity can 
be measured as its sensitivity, if the objective is demonstration of the absence of a hazard or to detect cases. 
It can also be measured as precision if prevalence is estimated or in terms of time to detection, if the main 
objective is early detection. This indicates that such performance indicators are dependent on the objective 
of a surveillance programme. The epidemiological performance can then be combined with the costs. For 
example, it could be calculated how much an increase of the sensitivity of a system by 5% would cost. 
Sometimes, the target effectiveness is pre-fixed, for example by an international standard or by legislation. 
Economic concerns then focus on selecting the least-cost option.
Risk-based surveillance has been promoted as a surveillance design with particularly high cost-
effectiveness. Over time, it has become clear that the advantages of this design depend on the context in 
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which it is applied. For example, it is particularly beneficial if applied in a low-prevalence situation where 
the risk factors for hazard occurrence are very well known. This allows targeting of a specific stratum in the 
population in which the hazard prevalence is expected to be higher. This will impact on the sample size that 
is required to achieve a defined performance level (e.g. probability of detection). However, the collection 
of information on risk factors also comes at a cost. Also, samples may be more expensive if they have to be 
collected from specified individuals or locations. The cost-effectiveness of risk-based surveillance therefore 
cannot be taken for granted and requires ex ante assessment.
The ultimate question to be answered, however, remains the following: “Is it worth it?” Whilst cost-
effectiveness of a programme starts to address this question by exploring whether increments in natural 
non-monetary effects (e.g. sensitivity) occur, this question is commonly intertwined with the interrogation 
of whether quantifiable benefits can be associated to each unit of cost allocated to the surveillance 
programme. A commonly used economic tool to assess the increments in benefits per unit of investment is 
cost-benefit analysis. Unlike cost-effectiveness, it uses monetary units to quantify costs and benefits and it 
has been often used in animal science and veterinary medicine (Babo Martins and Rushton, 2014). 
As described above, the costs are relatively easy to collect. However, the benefits may be more difficult 
to identify. Surveillance is conducted to provide information that is used for decision making in the context 
of animal or public health. If the information is not used in this way or no decisions are taken, surveillance 
has almost no value. This indicates that the benefits of surveillance cannot be assessed in isolation, but need 
to be considered in combination with the related interventions. A model for such economic assessments 
has been proposed by Häsler and colleagues (2011). Benefits of disease mitigation – now consisting of both 
surveillance and intervention – may be direct or indirect, tangible or intangible. A direct benefit would be 
increased productivity if a certain disease is absent. An indirect benefit would be that farmers’ income is 
increased and therefore they can afford better schooling for their children. A tangible benefit could be the 
access to a specific export market that requires freedom from a specific hazard. But there could also be 
intangible benefits, for example, peace of mind for the chief veterinary officer. Tangible or direct benefits are 
usually easier to translate into monetary units. In contrast, the valuation of intangible, indirect or temporary 
benefits is complex and consequently often not addressed in current economic assessments of animal 
health and food safety programmes.
The challenges of assessing benefits of surveillance become particularly obvious when surveillance 
systems are subject to evaluation. Evaluation is increasingly applied to assure that surveillance is achieving 
its objective. As long as the latter are defined in terms of effectiveness, this can be relatively straightforward. 
However, if efficiency or over-all value should be quantified, this can become quite challenging. Also, good 
practice is not yet fully established in this area although some first guidance is provided, for example through 
the RISKSUR project (www.fp7-risksur.eu).
All statements made so far are true for any surveillance, regardless of whether the main focus is on 
animal or public health. However, when surveillance is conducted in the context of food safety, benefits are 
expected also on the public health side. For some hazards, there may be animal health benefits too (e.g. 
brucellosis), but for some, these may be limited (e.g. Salmonella in pigs). Therefore, economic assessment 
of surveillance of such hazards needs to include costs as well as benefits incurred across animal and human 
populations, thus adding substantial complexity. 
We propose a framework that supports the mapping of cost and benefit streams of surveillance in a 
situation covering more than one population. The core concept is that surveillance will trigger certain 
activities (interventions) in either or both populations with the objective of risk mitigation. The benefits of 
these actions are then identified through the links established between surveillance and interventions, and 
– if possible – these are valued. This framework is currently being tested in the context of case examples, and 
our first experience revealed interesting results. For example, we hypothesise that a substantial proportion 
of surveillance conducted in animal populations for the benefit of public health has mainly intermediate 
or intangible benefits. This set of benefits is generated when surveillance data is used to, for example, 
inform risk assessments, identify gaps on surveillance systems, shape research agendas, or aid in outbreak 
investigation exercises, all of which contribute with knowledge that, whilst not triggering immediate actions 
of disease mitigation, can be used in future interventions. This stream of intangible benefits is linked to the 
value of knowledge in itself - intellectual capital - to the generation of social capital, and to the value of 
peace of mind (Babo Martins et al, submitted). As these are very difficult to value, the assumption, from a 
rational resource-use point of view, is that they are valuable enough for the user of the information (e.g. 
policy makers, risk assessors) to justify the current surveillance efforts and the resources allocated. The 
framework has not yet been applied to pig-related hazards, but to Campylobacter in chicken and West Nile 
virus. Results from these case examples will be presented and discussed. 
It is expected that evaluation – including economic evaluation – will become a routine activity in most 
disease mitigation programmes. This will also include food-borne risks. It is therefore recommended that 
stakeholder in the food industry develop technical competencies including not only epidemiology and risk 
assessment, but also surveillance and economics. 
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